Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Mallinckrodt
Queensland Health
Daiichi Sankyo
AstraZeneca
McKinsey

Generated: March 22, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: NILOTINIB HYDROCHLORIDE

« Back to Dashboard

NILOTINIB HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-51 28 CAPSULE in 1 BLISTER PACK (0078-0526-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-87 4 BLISTER PACK in 1 CARTON (0078-0526-87) > 28 CAPSULE in 1 BLISTER PACK
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-51 28 CAPSULE in 1 BLISTER PACK (0078-0592-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-87 4 BLISTER PACK in 1 CARTON (0078-0592-87) > 28 CAPSULE in 1 BLISTER PACK
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0951-66 120 CAPSULE in 1 BOTTLE, PLASTIC (0078-0951-66)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Julphar
Healthtrust
McKinsey
Federal Trade Commission